1 year return (CAGR)
-28.60%
Cara Therapeutic Exchange (NASDAQ, USD)
CARA
-
+2.29 (+14.34%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-66.35%
5 year return (CAGR)
-48.63%
10 year return (CAGR)
-26.44%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
27.82M
Price/Sales
3.20
Ent value
41.38M
Price/Book
39.35
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
434.49
EPS growth
1.20%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 17.56 |
| Daily high | 25.53 |
| Daily low | 15.50 |
| Daily Volume | 52K |
| 1y analyst estimate | 12.00 |
| Beta | 0.41 |
| EPS (TTM) | -62.70 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CARA | S&P500 | |
| Current price drop from All-time high | -98.26% | -14.24% |
| Highest price drop | -99.17% | -56.47% |
| Date of highest drop | 18 Jun 2024 | 9 Mar 2009 |
| Avg drop from high | -54.79% | -10.68% |
| Avg time to new high | 148 days | 12 days |
| Max time to new high | 1011 days | 1805 days |
News
No items found